0.59
0.008 (1.37%)
0.008 (1.37%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 583,785 |
|
|||||
News | - | ||||||
Day High | 0.612 | Low High |
|||||
Day Low | 0.561 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
VBI Vaccines Inc | VBIV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.58 | 0.561 | 0.612 | 0.60 | 0.582 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,238 | 583,785 | $ 0.577827 | $ 337,327 | - | 0.36 - 1.86 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:49:56 | 1 | $ 0.58 | USD |
VBI Vaccines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 152.37M | 258.26M | 191.22M | $ 631.00k | $ - | -0.27 | -1.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | - | 0.60% |
VBI Vaccines News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VBIV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.557 | 0.62 | 0.55 | 0.5763039 | 529,735 | 0.033 | 5.92% |
1 Month | 0.44 | 0.70 | 0.40005 | 0.5271922 | 963,876 | 0.15 | 34.09% |
3 Months | 0.65 | 0.70 | 0.36 | 0.5137586 | 1,060,507 | -0.06 | -9.23% |
6 Months | 0.85 | 1.35 | 0.36 | 0.7072297 | 994,300 | -0.26 | -30.59% |
1 Year | 1.73 | 1.86 | 0.36 | 1.02 | 1,616,659 | -1.14 | -65.9% |
3 Years | 1.34 | 7.24 | 0.36 | 2.86 | 4,806,764 | -0.75 | -55.97% |
5 Years | 3.96 | 7.24 | 0.36 | 2.58 | 3,457,106 | -3.37 | -85.1% |
VBI Vaccines Description
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. |